Glass House Brands is like:

• The Tyson Foods of cannabis, focusing on massive, low-cost cultivation and processing to supply the market.
• An Anheuser-Busch for cannabis, growing and distributing a wide array of cannabis products across different brands in a regulated market.

• Cannabis Flower: Cultivates and sells various strains of premium cannabis flower for recreational and medicinal use.
• Pre-rolls: Offers ready-to-consume cannabis pre-rolls, often featuring specific strains or blends.
• Edibles: Manufactures and distributes cannabis-infused edibles, such as gummies and chocolates.
• Vaporizer Products: Provides cannabis vape cartridges and disposable vape pens containing concentrated cannabis oil.
• Concentrates: Produces and sells highly potent cannabis concentrates, including live resin and rosin.

Glass House Brands (GLAS) operates as a vertically integrated cannabis company in California, encompassing large-scale cultivation, manufacturing, distribution, and retail operations. Based on their business model and revenue disclosures, Glass House Brands primarily sells its wholesale cannabis products to other licensed businesses.

Major Customers:

Glass House Brands' major customers are primarily other licensed businesses within the California cannabis market. Due to the fragmented nature of the cannabis industry and competitive considerations, Glass House Brands does not publicly disclose the specific names of its individual wholesale customer companies. Therefore, specific customer names, especially publicly traded ones, are not available. However, their major customers fall into the following categories:

• Licensed Cannabis Dispensaries: These are retail cannabis stores operating across California that purchase Glass House Brands' wholesale cannabis products (such as flower, pre-rolls, edibles, and vapes) for resale to individual consumers.
• Licensed Cannabis Distributors and Processors: Other businesses in the cannabis supply chain that may purchase Glass House Brands' bulk cannabis or finished products for further distribution to retailers or for use in their own manufacturing processes.

While Glass House Brands also operates its own chain of retail dispensaries (e.g., The Farmacy), selling directly to individual consumers, their significant cultivation capacity and wholesale revenue figures indicate that sales to other businesses constitute their primary customer base.

Kyle Kazan, Co-founder, Chairman & CEO

Kyle Kazan is a seasoned investor and expert manager of private equity funds with over two decades of domestic and international experience, known for growing de novo companies to industry leadership in fund/asset management, property management, and insurance. He began investing in real estate in 1991, eventually launching 23 private equity funds with properties valued above $2.75 billion. Kazan also served on the boards of multiple international investment and hedge funds before transitioning to the regulated cannabis industry in 2016, where he consolidated four funds to establish the vertically integrated Glass House Brands. He is also a co-founder of Beach Front Property Management, Inc. and Beach Front Properties, LLC.

Mark Vendetti, Chief Financial Officer

Mark Vendetti has held roles at iconic enterprises such as Procter and Gamble, Abercrombie and Fitch, Bauer Hockey, and Mattel. Prior to joining Glass House Brands, he served as the CFO of Canndescent, a leading producer of premium cannabis, from 2019 to 2021. From 2013 to 2015, he was the CFO of Francesca's, a women's specialty retailer, during a period of significant annual sales growth and store expansion.

Graham Farrar, Co-founder, President & Board Director

Graham Farrar is a serial entrepreneur who was part of the original team at Software.com, which went public in 1999. He was also a founding team member at Sonos, where he contributed to product design, development, sales, and customer support. Farrar founded and partnered in ebook publishers iStoryTime Inc. and zuuka, and established a luxury rental company in Santa Barbara. His entry into the regulated cannabis industry began with founding Elite Garden Wholesale, an agriculture technology company.

Hilal Tabsh, Chief Revenue Officer

Hilal Tabsh spent fifteen years at Red Bull, where he held positions such as head of sales and marketing strategy for the Middle East, Africa, and Pacific regions, and later oversaw sales, marketing, and distribution strategy for Red Bull North America. He co-founded and helped grow Limitless Beverage company, which was acquired by Keurig Dr. Pepper within three years of its founding. Subsequently, Hilal entered the cannabis industry, serving as Senior VP at BellRock Brands and then as Chief Revenue Officer at SlangWorldWide.

Benjamin Vega, General Counsel and Corporate Secretary

Benjamin Vega is a corporate lawyer with over 20 years of experience in complex business transactions and litigation across a range of industries, including Finance, Private Equity, M&A, Banking, Gaming and Hospitality, Media, Professional Sports, and Construction. Before joining Glass House Brands, he served as Deputy General Counsel for Covetrus, Inc., a public company in the animal health industry.

The key risks to Glass House Brands (GLAS) business include:

1. Regulatory Uncertainty and Evolving Taxation Policies: As a cannabis company, Glass House Brands operates in an industry highly susceptible to changing legislation, compliance requirements, and evolving taxation policies across federal, state, and local levels. This regulatory environment creates uncertainty for business expansion, market access, and operational stability. Recent immigration raids at its cultivation sites, though primarily framed as immigration enforcement, highlight the complex interplay of federal and state regulations and can significantly disrupt operations and production. The company's strategic shifts, such as uplisting to the NYSE and focusing on medical cannabis, are efforts to navigate these regulatory complexities, yet significant execution, regulatory, and capital risks persist.
2. Competitive Intensity and Pricing Pressure: Glass House Brands operates in maturing cannabis markets, particularly the saturated California market, leading to intense competition. This environment creates pricing pressure on products and can challenge the company's profit margins, even for low-cost producers. Evidence suggests declining margins and reduced profitability expectations, indicating that the ability to maintain profitability in a highly competitive market with potential oversupply is a significant concern.
3. Operational Execution and Financial Performance: The company faces risks related to operational execution, including challenges inherent in large-scale greenhouse cultivation concerning labor, regulation, and biological performance. Past immigration raids at Glass House facilities resulted in substantial cuts to production outlook (estimated at $25-$30 million) and could lead to increased labor costs due to tighter scrutiny and required changes in hiring practices. Financially, Glass House Brands has experienced earnings declines, negative adjusted EBITDA, negative operating cash flow, and has been noted to have less than one year of cash runway based on free cash flow trends, indicating ongoing financial performance and funding availability as critical risks.

Emerging Threats for Glass House Brands (GLAS):

• The development of cost-effective, scalable biosynthesis of cannabinoids (e.g., THC, CBD, and minor cannabinoids) could disrupt traditional cannabis cultivation. If cannabinoids can be produced in bioreactors more cheaply and consistently than through plant cultivation, it would diminish the competitive advantage and value proposition of large-scale agricultural operations like Glass House Brands, which rely on extensive plant-based cultivation for their product inputs.

• Potential federal policy changes in the U.S., such as the reclassification of cannabis to Schedule III, could pave the way for increased involvement from large pharmaceutical companies or established consumer packaged goods (CPG) giants. These entities possess vastly superior capital, marketing capabilities, research and development resources, and logistical networks. Their entry, particularly if accompanied by regulatory frameworks that allow for interstate commerce or national branding, could fundamentally alter the competitive landscape, making it difficult for state-focused, plant-touching operators like Glass House Brands to compete effectively on scale, price, or market reach.

Expected Drivers of Future Revenue Growth for Glass House Brands (GLAS)

• Increased Biomass Production and Cultivation Capacity Expansion: Glass House Brands anticipates significant revenue growth through the expansion of its cultivation capacity. The company has completed the final two-thirds of Greenhouse 2 construction and commenced the buildout of Greenhouse 4, aiming for a full-year 2026 biomass production target of approximately 1 million pounds, representing a roughly 50% increase from 2025. This enhanced production capability is expected to drive higher wholesale cannabis sales.
• Expansion into New Markets (Interstate Commerce and International Exports): The rescheduling of medical cannabis to Schedule III has created new opportunities for Glass House Brands to expand its market reach. The company has registered its cultivation and processing licenses under Schedule III, opening possibilities for interstate commerce and international exports, particularly targeting European medical cannabis markets. Additionally, the buildout of Greenhouse 4 is intended to target international CBD and hemp markets, further diversifying revenue streams beyond California.
• Growth in Retail Operations and Strategic Joint Ventures: Glass House Brands is focused on strengthening its retail footprint and customer base. The company has achieved six consecutive quarters of same-store retail sales growth through Q2 2025 and has formed a joint venture with Vireo to expand its retail operations in California, which is expected to enhance profitability and market reach.
• Reduced Production Costs: While an efficiency driver, achieving lower production costs is expected to positively impact revenue growth by allowing for more competitive pricing and improved margins. Glass House Brands aims to achieve an annual production cost target of $95 per pound on a quarterly basis in the second half of 2026, with overall production costs expected to decline as the year progresses. This cost reduction strategy is crucial for maintaining competitiveness and enhancing overall financial performance.

Share Issuance

• Glass House Brands raised $22.5 million of new capital in the third quarter of 2022.
• In the third quarter of 2023, the company recorded a $12.8 million inflow from a Series D Preferred Equity Fund Raise.
• The number of outstanding shares has increased from 23.19 million in 2020 to 81.72 million by the end of 2025 and as of July 2026, indicating ongoing share issuances.

Inbound Investments

• The company raised $22.5 million in new capital during the third quarter of 2022.
• Glass House Brands received a $12.8 million inflow from a Series D Preferred Equity Fund Raise in the third quarter of 2023.
• In December 2023, Glass House Brands closed a transaction to secure $15 million in funding from GH Group, Inc.

Outbound Investments

• In December 2021, Glass House Brands Inc. entered into a definitive agreement to acquire Plus Products Inc. for approximately $25.6 million, utilizing a combination of unsecured convertible debt and equity, along with performance-based consideration.
• The company acquired four retail locations in the third quarter of 2022 and further expanded by acquiring Natural Healing Center retail dispensaries in Grover Beach, Lemoore, and Morro Bay, California in September 2022.
• Glass House Brands completed the acquisition of the Turlock Natural Healing Center Dispensary in April 2023.

Capital Expenditures

• Capital expenditures placed into service led to an increase in depreciation and amortization from $2.8 million in Q2 2022 to $3.4 million in Q3 2022.
• The company spent approximately $5 million on capital expenditures in Q3 2023.
• In Q2 2025, Glass House Brands spent $9.5 million in capital expenditures, primarily focused on Phase III expansion at its Camarillo facility. The company also spent $3.5 million in capex in Q1 2026, mainly for the Phase III expansion at Camarillo.